STATE STREET CORP

Position in TVTX — Travere Therapeutics, Inc.

CIK 93751 BOSTON, MA

Back to TVTX Full portfolio

Position in TVTX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$241,796,085

+$94,434,842 QoQ

Shares Held

4,256,224

-14.2% QoQ

Ownership

4.52%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

of 315 holders

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 12% Shared 0% None 88%

Common Shares in TVTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,552,510,511 across 411 Biotechnology names. TVTX ranks #37 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	11,871,459	$5,896,909,829
2	REGN	Regeneron Pharmaceuticals, Inc.	4,834,688	$3,014,621,355
3	INCY	Incyte Corp	9,722,336	$1,102,124,008
4	MRNA	Moderna, Inc.	15,726,193	$1,101,305,295
5	ALNY	Alnylam Pharmaceuticals, Inc.	3,555,689	$1,070,369,059
6	RVMD	Revolution Medicines, Inc.	4,897,051	$917,119,711
7	RPRX	Royalty Pharma plc	12,338,229	$691,804,500
8	INSM	INSMED Inc	6,052,174	$645,282,791

All Filings in TVTX

Export CSV

27 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$241,796,085	4,256,224	-10.5%	Shares	Sole	2026-08-07
2026-06-30	$241,796,085	4,256,224	-14.2%	Shares	Defined	2026-08-07
2026-03-31	$147,361,243	4,959,988	+4.3%	Shares	Defined	2026-05-15
2025-12-31	$181,752,207	4,756,666	—	Shares	Sole	2026-02-09
2025-12-31	$181,752,207	4,756,666	+47.8%	Shares	Defined	2026-02-13
2025-09-30	$76,906,352	3,217,839	-7.6%	Shares	Defined	2025-11-14
2025-06-30	$51,551,004	3,483,176	-4.5%	Shares	Defined	2025-08-14
2025-03-31	$65,349,132	3,646,715	-3.2%	Shares	Defined	2025-05-15
2024-12-31	$65,625,233	3,767,235	+37.7%	Shares	Defined	2025-02-14
2024-09-30	$38,286,377	2,736,696	-22.0%	Shares	Defined	2024-11-14
2024-06-30	$28,857,764	3,510,677	-46.9%	Shares	Defined	2024-08-14
2024-03-31	$50,953,046	6,608,696	+23.5%	Shares	Defined	2024-05-15
2023-12-31	$48,117,581	5,352,345	+21.8%	Shares	Defined	2024-02-14
2023-09-30	$39,293,597	4,395,257	-23.3%	Shares	Defined	2023-11-14
2023-06-30	$88,053,288	5,732,636	+31.2%	Shares	Defined	2023-08-14
2023-03-31	$98,233,553	4,367,877	+3.4%	Shares	Defined	2023-05-15
2022-12-31	$88,831,224	4,224,024	+23.7%	Shares	Defined	2023-05-15
2022-09-30	$84,106,545	3,413,415	-5.4%	Shares	Defined	2022-11-15
2022-06-30	$87,401,607	3,607,165	+21.9%	Shares	Defined	2022-08-15
2022-03-31	$76,262,732	2,959,361	+2.5%	Shares	Defined	2022-05-16
2021-12-31	$89,614,870	2,887,077	+3.8%	Shares	Defined	2022-02-14
2021-09-30	$67,471,332	2,782,323	-19.4%	Shares	Defined	2021-11-15
2021-06-30	$50,391,802	3,453,859	+41.6%	Shares	Defined	2021-08-16
2021-03-31	$60,914,989	2,439,527	—	Shares	Defined	2021-07-09
2020-09-30 RTRX	—	1,920,415	+4.5%	Shares	Defined	2020-11-10
2020-06-30 RTRX	—	1,838,106	+6.5%	Shares	Defined	2020-08-14
2020-03-31 RTRX	—	1,725,572	—	Shares	Defined	2020-06-19
No filing history on record for this holder in this stock.